7/105 sources · 4 publishersUpdated Nov 10, 10:17 UTC
P3 Health Partners posts Q3 profit, lifts 2026 adjusted EBITDA outlook
P3 Health Partners reported third‑quarter 2026 revenue of $396.3 million, net income of $30.8 million and adjusted EBITDA of $20.9 million. Membership fell 9% YoY to about 105,000 while total lives under management were roughly 133,500. The company raised the low end of its full‑year adjusted EBITDA guidance to $90 million and lifted the midpoint to $100 million.
Why it matters
The higher adjusted EBITDA guidance signals stronger cash‑flow generation for 2026, which may improve valuation multiples. Management attributed the improvement to better medical‑cost trends, suggesting continued margin expansion.
Key facts
- 1Q3 2026 revenue was $396.3 million, up 15% from $345.3 million a year earlier. tradingview.com
- 2Net income for the quarter was $30.8 million, compared with a net loss in the prior‑year quarter. tradingview.com
- 3Adjusted EBITDA for the quarter was $20.9 million, versus a loss of $45.9 million a year earlier. tradingview.com
- 4Year‑to‑date adjusted EBITDA reached $101.1 million. tradingview.com
- 5The 2026 adjusted EBITDA guidance range is now $90 million to $110 million, with the midpoint raised to $100 million. tradingview.com
- 6At‑risk membership was approximately 105,000, down 9% year over year. tradingview.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.